Lotte Chemical Corporation (011170.KS)
Seoul, KR
Lotte Chemical Corporation, a leading chemical enterprise based in Seoul, South Korea, specializes in the global manufacturing and distribution of a diverse portfolio of polymers, monomers, fundamental petrochemicals, and products designed for emerging market trends. Established in 1976, the company's operations are structured across Monomer, Polymer, Basic Petrochemicals, and an 'Others' division. Its extensive polymer offerings include various grades of polyethylene (such as high-density, low-density, and linear low-density), ethylene-vinyl acetate, and polypropylenes suitable for applications like transparent-impact resistance, injection/blow molding, yarns/fibers, and films. The polymer range further extends to thermoplastic elastomers, adhesive resins, thermoplastic olefins, long fiber reinforced thermoplastics, expanded polypropylenes, polycarbonates, polycarbonate resins, acrylonitrile-butadiene-styrene (ABS) resins, and polyethylene terephthalates. Within its monomer segment, Lotte Chemical supplies ethylene glycols, ethylene oxides, methoxy polyethylene glycols, polyethylene glycols, VPEG (a crucial component for advanced admixtures), glycol ethers, methyl methacrylates, purified isophthalic acids, and purified terephthalic acids. The basic petrochemical division provides benzene, toluene, various xylene isomers (mixed, meta-, para-, and ortho-xylene), as well as isoprene, dicyclopentadiene, piperylene, and styrene monomers. The company also innovates with products like water treatment membranes. Beyond its core chemical activities, Lotte Chemical offers ancillary services including property leasing and labor dispatch. The firm maintains a significant international presence, operating in the Republic of Korea, Malaysia, the United States, Pakistan, China, and other global regions. The company, which was originally founded as Honam Petrochemical Corporation, officially rebranded to Lotte Chemical Corporation in December 2012.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.36% | -15.37% | -5.74% | +6.10% | +2.59% | +28.89% | +33.64% | -50.82% | -68.45% | -69.66% | +470.51% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 4 | -1 |
| Hold | 7 | 0 |
| Sell | 2 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals: +4.0%-9.5% Q1'26: +1.8% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-19.1% Q1'26: +125.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-5.6% Q1'26: -10.1% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-5.1% Q1'26: +1.5% (vs Q1'25)
-
ROIC Chemicals: +3.4%-3.9% Q1'26: +0.9% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.0% Q1'26: +1.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×42.52× Q1'26: 32.71× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 9 EPS Ana. |
Dec 2027 16 Rev. Ana. 11 EPS Ana. |
Dec 2028 14 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
11.71T
est: 11.84T (-1.1%)
|
13.22T
est: 12.99T (+1.8%)
|
15.87T
est: 15.89T (-0.1%)
|
16.55T
est: 16.48T (+0.4%)
|
15.12T
est: 15.54T (-2.7%)
|
12.22T
est: 12.29T (-0.5%)
|
18.12T
est: 17.54T (+3.3%)
|
22.28T
est: 22.45T (-0.8%)
|
19.95T
est: 19.71T (+1.2%)
|
20.43T
est: 20.73T (-1.4%)
|
18.48T
est: 18.87T (-2.0%)
|
20.35T
19.68T – 21.24T
+7.8% YoY
|
20.09T
16.37T – 23.90T
-1.2% YoY
|
19.25T
17.16T – 21.49T
-4.2% YoY
|
| EBITDA |
2.06T
est: 761.25B (+171.0%)
|
3.12T
est: 834.67B (+274.0%)
|
3.88T
est: 1.02T (+280.1%)
|
2.77T
est: 1.06T (+161.4%)
|
1.91T
est: 999.02B (+91.0%)
|
1.12T
est: 789.95B (+41.4%)
|
2.44T
est: 1.13T (+116.4%)
|
452.56B
est: 1.44T (-68.6%)
|
1.10T
est: 1.27T (-13.2%)
|
407.30B
est: 1.00T (-59.4%)
|
226.12B
est: 914.12B (-75.3%)
|
985.63B
953.37B – 1.03T
+7.8% YoY
|
973.46B
792.87B – 1.16T
-1.2% YoY
|
932.57B
831.13B – 1.04T
-4.2% YoY
|
| EBIT |
1.49T
est: 101.72B (+1,366.2%)
|
2.49T
est: 111.53B (+2,134.9%)
|
3.19T
est: 136.51B (+2,238.2%)
|
2.08T
est: 141.55B (+1,372.6%)
|
1.18T
est: 133.49B (+781.6%)
|
286.37B
est: 105.55B (+171.3%)
|
1.61T
est: 150.62B (+966.7%)
|
-495.36B
est: 192.83B (-356.9%)
|
-73.38B
est: 169.30B (-143.3%)
|
-883.38B
est: -130.54B (-576.7%)
|
-943.55B
est: -118.85B (-693.9%)
|
-128.14B
-133.76B – -123.95B
-7.8% YoY
|
-126.56B
-150.55B – -103.08B
+1.2% YoY
|
-121.25B
-135.35B – -108.06B
+4.2% YoY
|
| Net Income |
992.51B
est: 1.26T (-21.2%)
|
1.84T
est: 1.99T (-7.8%)
|
2.24T
est: 2.71T (-17.1%)
|
1.58T
est: 2.08T (-24.2%)
|
714.98B
est: 1.00T (-28.6%)
|
158.47B
est: 316.30B (-49.9%)
|
1.33T
est: 1.70T (-21.5%)
|
61.59B
est: 110.41B (-44.2%)
|
-50.04B
est: 57.04B (-187.7%)
|
-1.71T
est: -786.70B (-117.4%)
|
-2.04T
est: -960.50B (-112.1%)
|
-598.17B
-868.83B – -335.99B
+37.7% YoY
|
-222.19B
-1.34T – 699.89B
+62.9% YoY
|
-56.97B
-65.59B – -48.91B
+74.4% YoY
|
| SGA |
285.69B
est: 349.47B (-18.2%)
|
405.05B
est: 383.17B (+5.7%)
|
490.48B
est: 468.99B (+4.6%)
|
416.65B
est: 486.32B (-14.3%)
|
422.31B
est: 458.62B (-7.9%)
|
403.61B
est: 362.64B (+11.3%)
|
503.74B
est: 517.48B (-2.7%)
|
571.51B
est: 662.49B (-13.7%)
|
598.87B
est: 581.66B (+3.0%)
|
634.16B
est: 614.84B (+3.1%)
|
624.84B
est: 559.77B (+11.6%)
|
603.56B
583.81B – 630.01B
+7.8% YoY
|
596.11B
485.52B – 709.08B
-1.2% YoY
|
571.07B
508.95B – 637.51B
-4.2% YoY
|
| EPS |
28,252.00
est: 29,878.72 (-5.4%)
|
52,259.00
est: 47,230.14 (+10.6%)
|
62,940.00
est: 64,170.29 (-1.9%)
|
44,189.00
est: 49,387.78 (-10.5%)
|
20,006.00
est: 23,743.10 (-15.7%)
|
4,434.27
est: 7,501.02 (-40.9%)
|
37,319.00
est: 40,294.89 (-7.4%)
|
1,802.00
est: 2,618.29 (-31.2%)
|
-1,198.96
est: 1,352.80 (-188.6%)
|
-40,563.26
est: -18,657.28 (-117.4%)
|
-48,310.00
est: -22,778.95 (-112.1%)
|
-14,186.04
-20,605.06 – -7,968.38
+37.7% YoY
|
-5,269.43
-31,684.45 – 16,598.46
+62.9% YoY
|
-1,351.10
-1,555.43 – -1,160.04
+74.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dong-Bin Shin | Chairman of the Board & Chief Executive Officer | 2B | male |
| Young-jun Lee | President, Chief Executive Officer & Director | 625M | male |
| Kyung-Sun Park | Head of Monomer Division | — | — |
| Min-Woo Kim | New Business Division Head | — | — |
| Nak-Seon Sung | Chief Financial Officer & Inside Director | — | male |
| Sang-hyun Lee | Managing Director of Aromatic Business | — | — |
| Sung-Ki Kim | Deputy MD & Director of Legal Affairs Department | — | male |
| Sung-Taek Cho | Deputy MD & Director of Financial Accounting Department | — | male |
| Yoon-Seok Kim | Deputy MD and Director of HR Department & Purchasing Department | — | male |
| Young Kyung Hwang | Head of IR | — | — |
| Kyung Hoon Seo | Vice President & Head of the Battery Materials Strategy Division | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 011170.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
